scispace - formally typeset
D

David Miller

Researcher at University of Queensland

Publications -  41
Citations -  10011

David Miller is an academic researcher from University of Queensland. The author has contributed to research in topics: Pancreatic cancer & Biology. The author has an hindex of 23, co-authored 33 publications receiving 8083 citations. Previous affiliations of David Miller include Illumina & Garvan Institute of Medical Research.

Papers
More filters
Journal ArticleDOI

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey, +128 more
- 03 Mar 2016 - 
TL;DR: Detailed genomic analysis of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-β, WNT, NOTCH, ROBO/SLIT signalling, G1/S transition, SWI-SNF, chromatin modification, DNA repair and RNA processing.
Journal ArticleDOI

Whole genomes redefine the mutational landscape of pancreatic cancer.

Nicola Waddell, +88 more
- 26 Feb 2015 - 
TL;DR: Genomic instability co-segregated with inactivation of DNA maintenance genes (BRCA1, BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency, and 4 of 5 individuals with these measures of defective DNA maintenance responded to platinum therapy.
Journal ArticleDOI

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin, +140 more
- 15 Nov 2012 - 
TL;DR: It is found that frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, are also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement ofAxon guidance genes in pancreatic carcinogenesis.
Journal ArticleDOI

Whole-genome characterization of chemoresistant ovarian cancer

Ann-Marie Patch, +99 more
- 28 May 2015 - 
TL;DR: It is shown that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance.
Journal ArticleDOI

Whole-genome landscape of pancreatic neuroendocrine tumours

Aldo Scarpa, +129 more
- 02 Mar 2017 - 
TL;DR: In this paper, the authors performed whole-genome sequencing of 102 primary pancreatic neuroendocrine tumours and defined the genomic events that characterize their pathogenesis, including a deficiency in G:C,>T:A base excision repair due to inactivation of MUTYH, which encodes a DNA glycosylase.